Literature DB >> 18684506

Prevalence and causes of low vision and blindness in a rural chinese adult population: the Handan Eye Study.

Yuan Bo Liang1, David S Friedman, Tien Yin Wong, Si Yan Zhan, Lan Ping Sun, Jie Jin Wang, Xin Rong Duan, Xiao Hui Yang, Feng Hua Wang, Qiang Zhou, Ning Li Wang.   

Abstract

PURPOSE: To describe the prevalence and causes of low vision and blindness in a rural population in Northern China.
DESIGN: Population-based, cross-sectional study. PARTICIPANTS: A study of 6830 Han Chinese aged 30 years and older was conducted between October 2006 and October 2007 in rural Yongnian County in Handan, Northern China.
METHODS: Clustered samples of adults aged 30 years or more residing in 13 residential villages were selected randomly and were invited to participate the Handan Eye Study. Participants underwent a comprehensive eye examination, including standardized visual acuity (VA) tests using logarithm of the minimum angle resolution charts. Prevalence was age- and gender-standardized to the 2000 China Census. MAIN OUTCOME MEASURES: Low vision was defined as VA <20/60 but >/=20/400, and blindness was defined as VA <20/400 following the Modified World Health Organization (WHO) definitions. Primary causes of low vision and blindness were determined by study ophthalmologists according to WHO definitions.
RESULTS: Six thousand eight hundred thirty (90.4%) of 7577 eligible individuals participated in the study, and 6799 (89.7%) had VA data available. Population-weighted prevalence of presenting bilateral blindness was 0.6% and bilateral low vision was 4.7% for persons 30 years of age and older. Based on best-corrected visual acuity (BCVA), the corresponding prevalence of blindness was 0.5% and that of low vision was 1.0%. Blindness and low vision were strongly age related (P<0.05). Cataract was the predominant cause of presenting bilateral blindness (36.6%), whereas undercorrected refractive error was the predominant cause of presenting low vision (78.4%). After refractive correction, cataract became the first leading cause of blindness (41.9%), and low vision (48.2%), myopic retinopathy (16.1%), glaucoma (9.7%), and corneal opacity (9.7%) were other common causes of blindness defined using BCVA.
CONCLUSIONS: A higher prevalence of blindness and low vision was seen in this rural Chinese sample than has been reported from urban Chinese populations. The estimated numbers with BCVA-defined low vision and blindness in 2020, based on best-corrected vision in rural Chinese adults aged 30 years or more, is expected to be 12.4 million and 2.9 million, respectively. Predominant causes of low vision and blindness in China are treatable.

Entities:  

Mesh:

Year:  2008        PMID: 18684506     DOI: 10.1016/j.ophtha.2008.05.030

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  55 in total

1.  Changed trends of major causes of visual impairment in Sichuan, China from 1987 to 2006.

Authors:  Hui Chen; Ying-Chuan Fan; Qi-Hong He; Xiao-Yun Wu; Min Wei; June E Eichner; Bradley K Farris; P Lloyd Hildebrand; Chun-Tao Lei; Shu-Hua Wu; Jing-Yun Yang
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

2.  The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia.

Authors:  Sophie Rogers; Rachel L McIntosh; Ning Cheung; Lyndell Lim; Jie Jin Wang; Paul Mitchell; Jonathan W Kowalski; Hiep Nguyen; Tien Y Wong
Journal:  Ophthalmology       Date:  2010-02       Impact factor: 12.079

3.  Ocular Determinants of Refractive Error and Its Age- and Sex-Related Variations in the Chinese American Eye Study.

Authors:  Grace M Richter; Mingwu Wang; Xuejuan Jiang; Shuang Wu; Dandan Wang; Mina Torres; Farzana Choudhury; Rohit Varma
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

4.  Prevalence and causes of visual impairment and blindness in Sichuan province of China.

Authors:  Min Wei; Hui Chen; Ying-Chuan Fan; Sophia Pathai
Journal:  Int J Ophthalmol       Date:  2010-03-18       Impact factor: 1.779

5.  Prevalence and associations of cataract in a rural Chinese adult population: the Handan Eye Study.

Authors:  Xin Rong Duan; Yuan Bo Liang; Ning Li Wang; Tien Yin Wong; Lan Ping Sun; Xiao Hui Yang; Qiu Shan Tao; Rui Zhi Yuan; David S Friedman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-11       Impact factor: 3.117

6.  Prevalence and characteristics of peripheral myopic retinopathy in Guangzhou office workers.

Authors:  Ting Zhang; Yan-Tao Wei; Wen-Bin Huang; Rong-Jiao Liu; Ya-Jing Zuo; Li-Wen He; Li-Ting Zhong; Shao-Chong Zhang
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

7.  Prevalence of vision impairment in older adults in rural China: the China Nine-Province Survey.

Authors:  Jialiang Zhao; Leon B Ellwein; Hao Cui; Jian Ge; Huaijin Guan; Jianhua Lv; Xianzhi Ma; Jinglin Yin; Zheng Qin Yin; Yuansheng Yuan; Hu Liu
Journal:  Ophthalmology       Date:  2010-01-15       Impact factor: 12.079

8.  Prevalences and causes of vision impairment in elderly Chinese: a socioeconomic perspective of a comparative report nested in Jiangsu Eye Study.

Authors:  Rong-Rong Zhu; Jian Shi; Mei Yang; Huai-Jin Guan
Journal:  Int J Ophthalmol       Date:  2016-07-18       Impact factor: 1.779

9.  Inequities in Cataract Surgery and Postsurgical Quality-of-Life Outcomes in Handan, China.

Authors:  Lanping Sun; Jeffrey R Willes; Yuanbo Liang; Dolly S Chang; Xinrong Duan; Xiaohui Yang; Ningli Wang; David S Friedman
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2012-05

10.  Prevalence of Vision Impairment in Older Adults in Rural China in 2014 and Comparisons With the 2006 China Nine-Province Survey.

Authors:  Jialiang Zhao; Xiao Xu; Leon B Ellwein; Ning Cai; Huaijin Guan; Mingguang He; Ping Liu; Jianhua Lv; Xunlun Sheng; Peizeng Yang; Jinglin Yi; Mei Yang; Rui Zhang; Xiaohu Ding; Liping Du; Fengrong Li; Hong Lu; Wenqiang Shao; Junwei Wang; Yuansheng Yuan; Rui Zhou; Wenjuan Zhuang; Lei An
Journal:  Am J Ophthalmol       Date:  2017-11-02       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.